Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Daniel G. Welch currently holds 27,000 shares of INTERCEPT PHARMACEUTICALS INC (ICPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel G. Welch has been a net seller of ICPT stock. They have purchased $0 and sold $74.7M worth of shares.
Daniel G. Welch's most recent insider trade was on May 15, 2026, when they sold 27,000 shares at $0.00 per share.
Daniel G. Welch serves as Executive at INTERCEPT PHARMACEUTICALS INC (ICPT). They have executed 214 insider transactions totaling $74.7M over their tenure at the company.
Daniel G. Welch holds the position of Executive at INTERCEPT PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Daniel G. Welch has shown a selling trading pattern, with $0 in total purchases and $74.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Daniel G. Welch was on Dec 14, 2023, when they sold $2.5M worth of SGEN shares. This transaction involved 10,725 shares at $229.00 per share.
Daniel G. Welch currently owns 27,000 shares of INTERCEPT PHARMACEUTICALS INC (ICPT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Daniel G. Welch's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Daniel G. Welch has 214 Form 4 filings on record as an insider at INTERCEPT PHARMACEUTICALS INC.
Set alerts for Daniel G. Welch and 40,000+ other insiders.